title: Tripeptide LY301621 and its diastereomers as methicillin potentiators against methicillin resistant Staphylococcus aureus.
authors.affiliation: Infectious Diseases Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.
authors.forename: C N
authors.initials: CN
authors.lastname: Eid
authors.forename: N G
authors.initials: NG
authors.lastname: Halligan
authors.forename: T I
authors.initials: TI
authors.lastname: Nicas
authors.forename: D L
authors.initials: DL
authors.lastname: Mullen
authors.forename: T F
authors.initials: TF
authors.lastname: Butler
authors.forename: R J
authors.initials: RJ
authors.lastname: Loncharich
authors.forename: J W
authors.initials: JW
authors.lastname: Paschal
authors.forename: C J
authors.initials: CJ
authors.lastname: Schofield
authors.forename: N J
authors.initials: NJ
authors.lastname: Westwood
authors.forename: L
authors.initials: L
authors.lastname: Cheng
mesh_terms: D004357:Drug Synergism; D008712:Methicillin / Q000494:pharmacology*; D016106:Methicillin Resistance; D010406:Penicillins / Q000494:pharmacology*; D013211:Staphylococcus aureus / Q000187:drug effects*; D013237:Stereoisomerism
chemical_list: D010406:Penicillins; D008712:Methicillin